Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Tam

Showing results (611-620 of 922) with videos related to

Pageof 93
Sort By:
Leukemia|October 22, 2010
Therapy-related myelodysplastic syndrome and acute myeloid leukemia following fludarabine combination chemotherapyD A Carney, D A Westerman, C S Tam, et al.
Blood|October 24, 2015
Fludarabine, cyclophosphamide, and rituximab treatment achieves long-term disease-free survival in IGHV-mutated chronic lymphocytic leukemiaPhilip A Thompson, Constantine S Tam, Susan M O'Brien, et al.
Obesity (Silver Spring, Md.)|October 27, 2017
Intramyocellular Lipid Droplet Size Rather Than Total Lipid Content is Related to Insulin Sensitivity After 8 Weeks of OverfeedingJeffrey D Covington, Darcy L Johannsen, Paul M Coen, et al.
Therapeutic Advances in Medical Oncology|July 14, 2025
Efficacy of zanubrutinib versus acalabrutinib for relapsed or refractory chronic lymphocytic leukemia (R/R CLL): a matching-adjusted indirect comparison (MAIC)Mazyar Shadman, Jennifer R Brown, Rhys Williams, et al.
Leukemia & Lymphoma|October 15, 2015
Dose-reduced fludarabine, cyclophosphamide and rituximab is well tolerated in older patients with chronic lymphocytic leukemia and has preserved therapeutic efficacyThomas E Lew, Chan Y Cheah, Dennis A Carney, et al.
Journal of Inflammation|January 1, 1995
Novel intracellular signaling function of prostaglandin H synthase-1 in NF-kappa B activationD G Munroe, E Y Wang, J P MacIntyre, et al.
Clinical Chemistry|December 20, 2003
Improved accuracy of detection of nasopharyngeal carcinoma by combined application of circulating Epstein-Barr virus DNA and anti-Epstein-Barr viral capsid antigen IgA antibodySing-Fai Leung, John S Tam, Anthony T C Chan, et al.
The Journal of Nutrition, Health & Aging|April 14, 2012
Prospective observational study of isoflavone and the risk of stroke recurrence: potential clinical implications beyond vascular functionY-H Chan, K-K Lau, K-H Yiu, et al.
The British Journal of Ophthalmology|July 14, 2019
Association of the <i>ZC3H11B, ZFHX1B</i> and <i>SNTB1</i> genes with myopia of different severitiesShu Min Tang, Fen Fen Li, Shi Yao Lu, et al.
Leukemia Research|December 31, 2013
Phase I evaluation of XL019, an oral, potent, and selective JAK2 inhibitorSrdan Verstovsek, Constantine S Tam, Martha Wadleigh, et al.
Pageof 93

Showing results (611-620 of 922) with videos related to

Sort By:
Pageof 93
Leukemia|October 22, 2010
Therapy-related myelodysplastic syndrome and acute myeloid leukemia following fludarabine combination chemotherapyD A Carney, D A Westerman, C S Tam, et al.
Blood|October 24, 2015
Fludarabine, cyclophosphamide, and rituximab treatment achieves long-term disease-free survival in IGHV-mutated chronic lymphocytic leukemiaPhilip A Thompson, Constantine S Tam, Susan M O'Brien, et al.
Obesity (Silver Spring, Md.)|October 27, 2017
Intramyocellular Lipid Droplet Size Rather Than Total Lipid Content is Related to Insulin Sensitivity After 8 Weeks of OverfeedingJeffrey D Covington, Darcy L Johannsen, Paul M Coen, et al.
Therapeutic Advances in Medical Oncology|July 14, 2025
Efficacy of zanubrutinib versus acalabrutinib for relapsed or refractory chronic lymphocytic leukemia (R/R CLL): a matching-adjusted indirect comparison (MAIC)Mazyar Shadman, Jennifer R Brown, Rhys Williams, et al.
Leukemia & Lymphoma|October 15, 2015
Dose-reduced fludarabine, cyclophosphamide and rituximab is well tolerated in older patients with chronic lymphocytic leukemia and has preserved therapeutic efficacyThomas E Lew, Chan Y Cheah, Dennis A Carney, et al.
Journal of Inflammation|January 1, 1995
Novel intracellular signaling function of prostaglandin H synthase-1 in NF-kappa B activationD G Munroe, E Y Wang, J P MacIntyre, et al.
Clinical Chemistry|December 20, 2003
Improved accuracy of detection of nasopharyngeal carcinoma by combined application of circulating Epstein-Barr virus DNA and anti-Epstein-Barr viral capsid antigen IgA antibodySing-Fai Leung, John S Tam, Anthony T C Chan, et al.
The Journal of Nutrition, Health & Aging|April 14, 2012
Prospective observational study of isoflavone and the risk of stroke recurrence: potential clinical implications beyond vascular functionY-H Chan, K-K Lau, K-H Yiu, et al.
The British Journal of Ophthalmology|July 14, 2019
Association of the <i>ZC3H11B, ZFHX1B</i> and <i>SNTB1</i> genes with myopia of different severitiesShu Min Tang, Fen Fen Li, Shi Yao Lu, et al.
Leukemia Research|December 31, 2013
Phase I evaluation of XL019, an oral, potent, and selective JAK2 inhibitorSrdan Verstovsek, Constantine S Tam, Martha Wadleigh, et al.
Pageof 93